期刊论文详细信息
Reviews in Urology | |
Medical Treatment of Benign Prostatic Hyperplasia | |
Herbert Lepor1  | |
[1] New York University School of Medicine, New York, NY | |
关键词: Benign prostatic hyperplasia; Lower urinary tract symptoms; Monotherapy; Combination therapy; | |
DOI : | |
学科分类:基础医学 | |
来源: MedReviews, LLC | |
【 摘 要 】
Medical therapy for the treatment of benign prostatic hyperplasia (BPH) became an accepted standard of care in the 1990s following the reports of randomized, double-blind, placebo-controlled studies showing that finasteride, a 5-α reductase inhibitor, and terazosin, an α-blocker, significantly improved lower urinary tract symptoms and increased peak urinary flow rates in men with BPH. This article reviews novel approaches to the pharmacological treatment of BPH.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912040560371ZK.pdf | 586KB | download |